1/58
Immunodeficiencies, Autoimmunity, Hypersensitivity
Name the type of tolerance:
generative lymphoid organs
deletes immature self-reactive lymphocytes before maturation
HIGH affinity for self antigen induces apoptosis
B cells undergo receptor editing
T cells may develop into Treg cells
central tolerance
Name the type of tolerance:
outside bone marrow and thymus
regulates circulating autoreactive lymphocytes via anergy, apoptosis, Treg suppression, & lymphatic exclusion
peripheral tolerance
Name the type of hypersensitivity:
autoantibodies against cell-surface receptors or matrix/RBC antigens
Inflammation and cell or tissue damage secondary to antibody binding
organ-specific
EX: Graves, Myasthenia gravis, Goodpasture’s syndrome, autoimmune hemolytic anemia
Type II
Name the type of hypersensitivity:
circulating antigen-antibody immune complexes deposit in vessels/tissue
systemic
EX: SLE, Rheumatoid arthritis
Type III
Name the type of hypersensitivity:
T cell-mediated injury
CD4+ macrophage activation
CD8+ CTL killing
systemic
EX: Type 1 diabetes, multiple sclerosis, celiac disease, rheumatoid arthritis
Type IV
Name the Autoimmune Disease phase:
genetic & environmental triggers cross tolerance threshold
pt. is unaware of symptoms
initiation phase
Name the Autoimmune Disease phase:
self-perpetuating inflammation
epitope spreading
tissue damage
propagation phase
Name the Autoimmune Disease phase:
Treg restores Teff/Treg balance
Persistent struggle causes relapsing and remitting clinical course
resolution phase
Name the type of T Cells
naturally in thymus or induced peripherally
depend on IL-2 for survival
inhibits activation/differentiation of B cells, NK cells, & naive T cells into effector T cells
EX: CD4+, CD25+, FoxP3+, Treg
regulatory T cells
Describe the mechanism of Regulatory T cells:
Inhibitory cytokines
Secrete IL-10 and TGF-B to inhibit self reactive T cells
Describe the mechanism of Regulatory T cells:
Co-stimulatory blockade
Express CTLA-4 which blocks or removes B7 on APCs, preventing CD28 co-stimulation
TCR signaling disrupted
anergy induced in autoreactive T cells
Describe the mechanism of Regulatory T cells:
IL-2 consumption
High surface expression of IL-2 receptor consumes IL-2, starving nearby autoreactive T cells
Name the Risk Factor / Gene:
Associated disease: ankylosing spondylitis
Presentation: inflammatory disease of vertebral joints
HLA-B27
Name the Risk Factor / Gene:
Associated disease: APS-1 (autoimmune polyendocrine syndrome-1)
Presentation: Loss of thymic tissue-specific self-antigen expression → failure of central tolerance → multi-organ endocrine autoimmunity
No negative selection
AIRE mutation
Name the Risk Factor / Gene:
Associated disease: IPEX syndrome (X-linked)
Presentation: Loss of functional CD4+, CD25+ Treg cells → failure of peripheral tolerance → multi-organ polyendrocrinopathy & enteropathy
Impaired Treg function
FoxP3 mutation
Name the Risk Factor / Gene:
Associated disease: Rheumatic fever (or general autoimmunity)
Presentation:
Infections induce APC co-stimulation (B7)
In Rheumatic fever, antibodies cross-react (molecular mimicry) with heart/joint/kidney epitopes → complement inflammation → heart failure
Bacterial and self antigens appear similar
DAMPs (infections / sterile necrosis)
Name the Risk Factor / Gene:
Associated disease: Sympathetic ophthalmia
Presentation: Rupture of eye releases immune-privileged proteins → autoimmune attack on both eyes → blindness unless enucleated or immunosuppressed
physical trauma (sequestered antigens)
Name the Risk Factor / Gene:
Associated disease: Celiac disease
Presentation: Gluten peptides activate CD4+ T cells → macrophage activation → small intestine damage & inflammation
Diet / Gluten + HLA-DQ2 / DQ8
Name the autoantibody mechanism:
Autoantibody mimics natural ligand → sustained activation of downstream signaling
Associated disease: Graves’, Autoimmune hypoglycemia
Receptor agonist
Name the autoantibody mechanism:
Autoantibody binds receptor and blocks natural ligand → inhibition of signaling / receptor endocytosis
Associated disease: Myasthenia gravis, T2DM
Receptor antagonist
Name the autoantibody mechanism:
Opsonizes cells for phagocytosis, fixes complement on cell surface, & recruits FcR+ leukocytes
Associated disease: Goodpasture’s syndrome, Autoimmune hemolytic anemia
opsonization and complement
Name the Injury Mechanism
Circulating Antigen-Antibody complexes deposit in blood vessel walls, kidney glomeruli, joints → fix complement & recruit neutrophils/macrophages → acute vasculitis / nephritis
EX: In SLE, pDCs sense endogenous RNA/DNA via TLR7/TLR9 → MyD88 → IFN-a → induces BAFF → drives autoreactive B-cell autoantibody production
immune complex-mediated injury
Name the Injury Mechanism
New epitopes are recognized by an existing autoimmune response → initiating new autoantibodies that amplify disease
EX: In SLE, an H1-specific B cell binds and internalizes entire nucleosome → presents H1-3 peptides on MHCII → as tissue damage releases intact nucleosomes, H2-3 B cells bind the complex and present H1 to an H1 specific T cell → anti H2-3 autoantibodies produced
epitope spreading
Name the type of T cell involved T Cell-Mediated Injury
Secrete IFN-y to activate macrophages → inflammatory tissue injury
Associated disease: Multiple sclerosis, Rheumatic diseases
CD4+ TH1 Cells
Name the type of T cell involved T Cell-Mediated Injury
Directly kill self-cells expressing target antigen
Infiltrate pancreatic islets and release destructive enzymes
Later CD4+ T cells activate macrophages and autoantibodies
CD8+ CTLs
Name the Structure associated w/ the Mechanism
Chronic infilitrates organize into lymph node-like structures with T/B zones, DCs, and germinal centers supporting local isotype switching and antibody production
Persistent swelling of salivary gland, rising antibody levels
Associated disease: Hashimoto’s thyroiditis, Sjogren’s syndrome
tertiary lymphoid tissues
Name the 4 steps of Nucleosome Epitope Spreading & Cycle of Tissue Damage in SLE
Tissue damage (releases nuclear antigens)
Immune complex (IgG + nuclear antigens form and trap in blood vessels)
Inflammation (complement and FcRs recruite immune cells)
Amplified injury & epitope spreading (cells damage tissue trying to clear ICs → H1 T cell helps H2/3 B cells
Name the Structure
IgM, IgG, or IgA autoantibodies that bind the Fc region of human IgG
Drives pro-inflammatory cytokine releasem inflammatory cell recruitment, and complement activation
Rheumatoid factor (RF)
What cells collaborate in all autoimmune rheumatic diseases?
B and T cells
Name the Disease / Disorder
Autoantibodies against nuclear antigens (DNA histones)
Driven by Type III immune complex deposition, pDC IFN-a/BAFF axis, nucleosome epitope spreading
Symptoms: fever, weakness, arthritis, skin rashes, kidney dysfunction
Systemic Lupus Erythematosus (SLE)
Name the Disease / Disorder
RF forms in serum, synovial fluid, cartilage → complement
Stress/infection induces PAD enzyme converting arginine to citrulline in cytoskeletal proteins
Thymus lacks citrullinated proteins → autoreactive T cells escape central tolerance → citrullinated peptides bind HLA-DR4 → ACPA activates macrophages, fibroblast migration, osteoclast differentiation, complement
Symptoms: chronic inflammatory synovitis w/ progressive bone and cartilage destruction
Rheumatoid Arthritis (RA)
Name the Disease / Disorder
Initiated by glandular injury → CD4+ T cell differentiation into follicular helper T cells (TFH) → recruits B/T cells → cytokines/chemokines sustain B cell survival & plasma cell autoantibodies secretion in a positive feedback loop
Symptoms: dry eyes, dry mouth, tertiary lymphoid follicles w/ germinal centers
Sjogren’s Syndrome
Name the Disease / Disorder
Anti-TSH receptor antibodies stimulate thyroid hormone synthesis and release (hyperthyroidism)
Receptor agonist
Type II
Graves’ disease
Name the Disease / Disorder
Anti-insulin receptor antibodies stimulate continual glucose uptake
Receptor agonist
Autoimmune hypoglycemia
Name the Disease / Disorder
Anti-ACh receptor antibodies induces receptor endocytosis and degradation on muscles cells leading to msucle weakness
Receptor antagonist
Type II
Myasthenia gravis
Name the Disease / Disorder
Anti-insulin receptor antibodies block glucose uptake
Receptor Antagonist
T2DM
Name the Disease / Disorder
Anti-collagen (basement membrane) antibodies in kidney glomeruli and lung alveoli recruits inflammatory cells
Type II
Goodpasture’s syndrome
Name the Disease / Disorder
Anti-RBC antibodies → complement-mediated phagocytosis and hemolysis
Type II
Autoimmune hemolytic anemia
Name the Disease / Disorder
Mutation in common gamma chain
Loss of IL-7 & IL-15 signaling halts T & NK cell development
B cells are present in normal #s, but non-functional due to lack of T cell help
Presents as oral thrush, persistent diaper rash, failure to thrive, and opportunistic infections in infancy
X-linked SCID
Name the Disease / Disorder
Defective JAK3 or ADA/PNP which accumulates toxic dATP and inhibits DNA synthesis or RAG 1/2, Artemis which affects VDJ recombination
Complete absence of both T and B cells
NK cells present but neither cell-mediated nor T-dependent humoral responses occur
Autosomal recessive SCID
Name the Disease / Disorder
Defects in CIITA or RFX controlling HLA class II gene expression
No surface MHCII leads to CD4+ T cells fail positive selection
APCs cannot present antigens to any remaining CD4+ T cells
Autosomal recessive
Bare Lymphocyte Syndrome Type II
Name the Disease / Disorder
Defect in TAP impairs peptide loading onto HLA class I
Low surface MHCI leads to deficient CD8+ T cells
Less severe than its other type
Bare Lymphocyte Syndrome Type I
Name the Disease / Disorder
Mutation in BTK leads to failure of pre-BCR signal and arrests differentiation of pre-B cells into mature B cells
Absent B cells and absent serum Ig
Normal T cells
X-linked
Presents after 6 months
Bruton’s disease (agammaglobulinemia)
Name the Disease / Disorder
Mutation in CD40L (on activated CD4+ T cells) or CD40(on B cells/macrophages)
CD40L is X-linked
CD40 is autosomal recessive
Blocks T-dependent B-cell activation, isotype switching, & macrophage activation
Normal or elevated IgM w/ decreased IgG, IgA, IgE
Absent germinal centers
Hyper-IgM Syndrome
Name the Disease/ Disorder
Block in differentiation of mature B cells into plasma cells
Causes Hypogammaglobulinemia despite normal mature B cell counts
Affects both sexes equally
Later onset (childhood/adolescence)
Common Variable Immunodeficiency (CVID)
Name the Disease / Disorder
Mutation in B2 integrin subunit (CD18) shared by LFA-1 and Mac-1
Fails firm adhesion to endothelial ICAM-1
No leukocytes migrate to infection sites
Complete lack of pus
Poor wound healing
Recurrent infections
Autosomal recessive
Leukocyte Adhesion Deficiency 1 (LAD-1)
Name the Disease / Disorder
Mutation in fucosyl transferase
Lacks sialyl-lewis X ligand for E & P selections
Fails rolling
No leukocytes migrate to infection sites
Complete lack of pus
Poor wound healing
Recurrent infections
Autosomal recessive
Leukocyte Adhesion Deficiency 2 (LAD-2)
Name the Disease / Disorder
Mutation in subunits of NADPH oxidase
Most commonly X-linked phox-91
Fails to generate superoxide & ROS respiratory burst in neutrophils and macrophages
Chronic macrophage-rich inflammation forms granulomas
Chronic granulomatous Disease (CGD)
What type of virus is HIV?
retrovirus
Name the 4 cellular targets of HIV (as listed in lecture)
CD4+ T cells (killed via cytopathic replication or CTL lysis)
Macrophages (via CCR5/phagocytosis; resistant to lysis)
Mucosal Dendritic cells (transport HIV to lymph nodes)
B cells (not infected but nonfunctional due ot lack of T-cell help)
Name the phase of HIV
Mucosal CCR5+ DCs/Mφ → LN CXCR4+ CD4+ T
High viremia
CD8+ CTLs & seroconversion lower viral load
acute phase (0-12 weeks)
Name the phase of HIV
Clinically asymptomatic
Low-level replication in lymphoid tissues
Steady progressive loss of CD4+ T cells
Chronic latency (years)
Name the phase of HIV
Viremia spikes
Fever > 1 month, opportunistic infections, sarcoma, B-cell lymphoma, CNS disease
Treated w/ ART & IRIS
AIDS
Name the HIV treatment
>3 antiretroviral drugs to suppress viral replication
Halts CD4+ T-cell loss
Slowly restores peripheral CD4+ counts
ART
Name the HIV treatment
2-3 weeks after starting antiretroviral therapy
Recovering T cells mount exaggerated inflammatory responses to pre-existing opportunistic pathogens
Activates neutrophils vial IL-1 to release tissue-damaging MMPs
Immune Reconstitution Inflammatory Syndrome (IRIS)
Age-related decline in immune function reducing protection against infections, vaccines, and cancers
Immunosenescence
Gradual increase in chronic sterile inflammation with age independent of acute/chronic disease, driving long-term tissue damage, autoimmunity, and degenerative disease
Inflammaging
Describe the difference between a Neonatal & Aged Immune System
Hematopoiesis & Thymus
Neonatal: innate cells appear in 1st trimester, adaptive cells in 2nd trimester
monocytes/DCs (4 weeks)
granulocytes/NK (8 weeks)
Describe the difference between a Neonatal & Aged Immune System
Hematopoiesis & Thymus